Clinical trial
To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin…
NCT00143338 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00143338 |
|---|---|
| Title | To Examine the Lung When People With Diabetes Take an Inhaled Form of Insulin, Compared to Subcutaneous Insulin. |
| Official title | A Phase 2, Exploratory Study to Examine the Effects of Inhaled Insulin, Compared With Subcutaneously Administered Insulin, on Airway Lining Fluid Composition in Subjects With Type 2 Diabetes Mellitus. |
| Lead sponsor | Pfizer, Industry |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Inhaled insulin |
| Enrollment | 20 |
| Start date | Nov 1, 2004 |
| Completion | Dec 1, 2006 |
| First posted | Sep 2, 2005 |
| Last update posted | Feb 12, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: